Number of the records: 1  

Recombinant fragment of an antibody tailored for direct radioiodination

  1. 1.
    SYSNO ASEP0378891
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleRecombinant fragment of an antibody tailored for direct radioiodination
    Author(s) Sedláček, Juraj (UMG-J) RID
    Fábry, Milan (UMG-J) RID
    Sieglová, Irena (UMG-J)
    Král, Vlastimil (UMG-J) RID
    Uhnáková, Bronislava (UMG-J)
    Mudra, M. (SK)
    Kronrád, L. (CZ)
    Sawicka, A. (PL)
    Mikolajczak, R. (PL)
    Řezáčová, Pavlína (UMG-J) RID
    Source TitleJournal of Labelled Compounds and Radiopharmaceuticals. - : Wiley - ISSN 0362-4803
    Roč. 55, č. 1 (2012), s. 52-56
    Number of pages5 s.
    Languageeng - English
    CountryGB - United Kingdom
    KeywordsI125 labelling ; single-chain antibody variable fragment ; tyrosine-rich polypeptide segment ; fusion protein
    Subject RIVEB - Genetics ; Molecular Biology
    R&D Projects2A-2TP1/076 GA MPO - Ministry of Industry and Trade (MPO)
    1M0505 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    CEZAV0Z50520514 - UMG-J (2005-2011)
    UT WOS000299555700010
    DOI10.1002/jlcr.1945
    AnnotationHigh specific radioactivity (per mass or per mole) is an important and desirable parameter for the radiopharmaceuticals that are intended to target disease biomarker molecules. In direct radioiodination of immunoglobulins or their fragments, the predominant chemical reaction is usually the monoiodination of the phenol rings of tyrosine amino acid residues. For such radioiodination, the maximum achievable level of labeling of a given protein molecule obviously correlates to the number of solvent-accessible tyrosine residues. The grafting of proteins with additional iodine-acceptor tyrosine residues by conventional chemical techniques has been recently reported. We show here that a recombinant single chain variable fragment (scFv) of an anti-b-III-tubulin antibody, having a potential use in imaging neural lesions or astrocytoma and certain nonneuronal tumors, can be modified in a similar manner. However, in contrast to previously published examples, tyrosine residues are added to the polypeptide main chain without any chemical reaction, solely with molecular cloning and recombinant expression. Importantly, the tailoring outlined here is carried out ‘once and for all’ at laboratory scale (modifying permanently the expressed nucleic acid), whereas chemical indirect methods are necessarily carried out either at production scale or always before each round of radioiodination.
    WorkplaceInstitute of Molecular Genetics
    ContactNikol Škňouřilová, nikol.sknourilova@img.cas.cz, Tel.: 241 063 217
    Year of Publishing2013
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.